Hospital Drug Survey: Ranmark And Lunesta On Top
This article was originally published in PharmAsia News
Executive Summary
According to a Mix Online survey on medicine adopted by hospitals to compare the efficacy of old and new drugs, Daiichi Sankyo bone lesion drug Ranmark (denosumab) placed first and Eisai insomnia drug Lunesta (eszopiclone) placed second.